EMA validates Type II Variation marketing application for Enhertu as post-neoadjuvant treatment for patients with HER2 positive earlybreast cancer: Tokyo Saturday, February 21, 20 ...
Researchers from the Southern University of Science and Technology, reporting on November 28, 2025, in Microsystems & Nanoengineering, describe a new optoelectrowetting-based droplet dispensing system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results